Flunarizine Hydrochloride Capsules have symptomatic relief for vertebral artery-type cervical spondylosis, but this product is mainly used to treat vertigo caused by vestibular dysfunction and so on.
Flunarizine Hydrochloride Capsules can inhibit cerebral vasospasm and improve cerebral blood flow. Vertebral artery in vertebral artery-type cervical spondylosis due to pressure, causing vasospasm, so that the cerebral blood flow is reduced, taking Flunarizine Hydrochloride Capsules can improve this situation, thus improving the symptoms of dizziness, headache and so on.
However, Flunarizine Hydrochloride Capsules cannot reach the therapeutic effect for other types of cervical spondylosis such as neurogenic, sympathetic, and spinal cord types.
Flunarizine Hydrochloride Capsules are mainly used for the prophylactic treatment of typical or atypical migraine and symptomatic treatment of vertigo caused by vestibular dysfunction.
This product may cause adverse reactions such as rhinitis, increased appetite, somnolence, depression, and constipation. The drug is contraindicated in people with Parkinson’s disease, history of depression, other extrapyramidal disorders, and those who are allergic to the product. The drug should be used under the supervision of a doctor.